Global Biologics and Biosimilars Market By Product Type (Monoclonal Antibodies, Interferon, Erythropoietin) And By End-Users/Application (Tumor, Diabetes, Cardiovascular) Global Market Share, Forecast Data, In-Depth Analysis, And Detailed Overview, and Forecast, 2013 – 2026

The Biologics and Biosimilars market report provides historical data along with future forecast and detailed analysis for Biologics and Biosimilars on a global and regional level. In this report, the global Biologics and Biosimilars market is valued at USD XX million in 2018 and is expected to reach USD XX million by the end of 2026, growing at a CAGR of XX% between 2019 and 2026. The study provides us with historical data along with forecast from 2019 to 2026. This research study helps the purchaser to understand the various drivers and restraints impacting Biologics and Biosimilars market during the forecast period. Additionally the study provides expected opportunities in Biologics and Biosimilars The Biologics and Biosimilars market research report provides a comprehensive study on production capacity, consumption, import and export for all major regions across the globe. The report covers an in depth description, competitive scenario, wide product portfolio of key vendors and business strategy adopted by competitors along with their SWOT analysis. To report various factors impacting the Biologics and Biosimilars the research study further incorporates Porter’s five forces model for the Biologics and Biosimilars market. The study encompasses a market attractiveness analysis, wherein each segment is benchmarked based on its market size, growth rate, and general attractiveness. The report is prepared by data received from in-house databases, secondary as well as primary research team comprising of various industry experts. The report has been prepared based on the synthesis, analysis, and interpretation of information about the global Biologics and Biosimilars market collected from specialized sources. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. Company overview, financial overview, product portfolio, new project launched, recent development analysis are the parameters included in the profile. The major manufacturer operating into Biologics and Biosimilars market include: Roche Amgen AbbVie Sanofi-Aventis Johnson & Johnson Pfizer Novo Nordisk Eli Lilly Novartis Merck 3sbio Changchun High Tech CP Guojian Biotech Gelgen Innovent Dong Bao Ganlee This report segments the global Biologics and Biosimilars market as follows: Global Biologics and Biosimilars Market: Type Segment Analysis Monoclonal Antibodies Interferon Erythropoietin Insulin Vaccines Other Global Biologics and Biosimilars Market: Application Segment Analysis Tumor Diabetes Cardiovascular Hemophilia Other Global Biologics and Biosimilars Market: Regional Analysis North America (U.S., Canada, Mexico) Europe (U.K., France, Germany, Spain, Italy, Central , Eastern Europe, CIS) Asia Pacific (China, Japan, South Korea, ASEAN, India, Rest of Asia Pacific) Latin America (Brazil, Rest of L.A.) Middle East And Africa(Turkey, GCC, Rest of Middle East)
Table of Contents 1 Market Overview 1.1 Biologics and Biosimilars Introduction 1.2 Market Analysis by Type 1.2.1 Monoclonal Antibodies 1.2.2 Interferon 1.2.3 Erythropoietin 1.2.4 Insulin 1.2.5 Vaccines 1.2.6 Other 1.3 Market Analysis by Applications 1.3.1 Tumor 1.3.2 Diabetes 1.3.3 Cardiovascular 1.3.4 Hemophilia 1.3.5 Other 1.4 Market Analysis by Regions 1.4.1 North America (United States, Canada and Mexico) 1.4.1.1 United States Market States and Outlook (2014-2024) 1.4.1.2 Canada Market States and Outlook (2014-2024) 1.4.1.3 Mexico Market States and Outlook (2014-2024) 1.4.2 Europe (Germany, France, UK, Russia and Italy) 1.4.2.1 Germany Market States and Outlook (2014-2024) 1.4.2.2 France Market States and Outlook (2014-2024) 1.4.2.3 UK Market States and Outlook (2014-2024) 1.4.2.4 Russia Market States and Outlook (2014-2024) 1.4.2.5 Italy Market States and Outlook (2014-2024) 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) 1.4.3.1 China Market States and Outlook (2014-2024) 1.4.3.2 Japan Market States and Outlook (2014-2024) 1.4.3.3 Korea Market States and Outlook (2014-2024) 1.4.3.4 India Market States and Outlook (2014-2024) 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024) 1.4.4 South America, Middle East and Africa 1.4.4.1 Brazil Market States and Outlook (2014-2024) 1.4.4.2 Egypt Market States and Outlook (2014-2024) 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024) 1.4.4.4 South Africa Market States and Outlook (2014-2024) 1.4.4.5 Turkey Market States and Outlook (2014-2024) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 2 Manufacturers Profiles 2.1 Roche 2.1.1 Business Overview 2.1.2 Biologics and Biosimilars Type and Applications 2.1.2.1 Product A 2.1.2.2 Product B 2.1.3 Roche Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.2 Amgen 2.2.1 Business Overview 2.2.2 Biologics and Biosimilars Type and Applications 2.2.2.1 Product A 2.2.2.2 Product B 2.2.3 Amgen Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.3 AbbVie 2.3.1 Business Overview 2.3.2 Biologics and Biosimilars Type and Applications 2.3.2.1 Product A 2.3.2.2 Product B 2.3.3 AbbVie Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.4 Sanofi-Aventis 2.4.1 Business Overview 2.4.2 Biologics and Biosimilars Type and Applications 2.4.2.1 Product A 2.4.2.2 Product B 2.4.3 Sanofi-Aventis Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.5 Johnson & Johnson 2.5.1 Business Overview 2.5.2 Biologics and Biosimilars Type and Applications 2.5.2.1 Product A 2.5.2.2 Product B 2.5.3 Johnson & Johnson Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.6 Pfizer 2.6.1 Business Overview 2.6.2 Biologics and Biosimilars Type and Applications 2.6.2.1 Product A 2.6.2.2 Product B 2.6.3 Pfizer Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.7 Novo Nordisk 2.7.1 Business Overview 2.7.2 Biologics and Biosimilars Type and Applications 2.7.2.1 Product A 2.7.2.2 Product B 2.7.3 Novo Nordisk Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.8 Eli Lilly 2.8.1 Business Overview 2.8.2 Biologics and Biosimilars Type and Applications 2.8.2.1 Product A 2.8.2.2 Product B 2.8.3 Eli Lilly Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.9 Novartis 2.9.1 Business Overview 2.9.2 Biologics and Biosimilars Type and Applications 2.9.2.1 Product A 2.9.2.2 Product B 2.9.3 Novartis Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.10 Merck 2.10.1 Business Overview 2.10.2 Biologics and Biosimilars Type and Applications 2.10.2.1 Product A 2.10.2.2 Product B 2.10.3 Merck Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.11 3sbio 2.11.1 Business Overview 2.11.2 Biologics and Biosimilars Type and Applications 2.11.2.1 Product A 2.11.2.2 Product B 2.11.3 3sbio Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.12 Changchun High Tech 2.12.1 Business Overview 2.12.2 Biologics and Biosimilars Type and Applications 2.12.2.1 Product A 2.12.2.2 Product B 2.12.3 Changchun High Tech Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.13 CP Guojian 2.13.1 Business Overview 2.13.2 Biologics and Biosimilars Type and Applications 2.13.2.1 Product A 2.13.2.2 Product B 2.13.3 CP Guojian Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.14 Biotech 2.14.1 Business Overview 2.14.2 Biologics and Biosimilars Type and Applications 2.14.2.1 Product A 2.14.2.2 Product B 2.14.3 Biotech Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.15 Gelgen 2.15.1 Business Overview 2.15.2 Biologics and Biosimilars Type and Applications 2.15.2.1 Product A 2.15.2.2 Product B 2.15.3 Gelgen Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.16 Innovent 2.16.1 Business Overview 2.16.2 Biologics and Biosimilars Type and Applications 2.16.2.1 Product A 2.16.2.2 Product B 2.16.3 Innovent Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.17 Dong Bao 2.17.1 Business Overview 2.17.2 Biologics and Biosimilars Type and Applications 2.17.2.1 Product A 2.17.2.2 Product B 2.17.3 Dong Bao Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.18 Ganlee 2.18.1 Business Overview 2.18.2 Biologics and Biosimilars Type and Applications 2.18.2.1 Product A 2.18.2.2 Product B 2.18.3 Ganlee Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 3 Global Biologics and Biosimilars Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018) 3.1 Global Biologics and Biosimilars Sales and Market Share by Manufacturer (2017-2018) 3.2 Global Biologics and Biosimilars Revenue and Market Share by Manufacturer (2017-2018) 3.3 Market Concentration Rate 3.3.1 Top 3 Biologics and Biosimilars Manufacturer Market Share in 2018 3.3.2 Top 6 Biologics and Biosimilars Manufacturer Market Share in 2018 3.4 Market Competition Trend 4 Global Biologics and Biosimilars Market Analysis by Regions 4.1 Global Biologics and Biosimilars Sales, Revenue and Market Share by Regions 4.1.1 Global Biologics and Biosimilars Sales and Market Share by Regions (2014-2019) 4.1.2 Global Biologics and Biosimilars Revenue and Market Share by Regions (2014-2019) 4.2 North America Biologics and Biosimilars Sales and Growth Rate (2014-2019) 4.3 Europe Biologics and Biosimilars Sales and Growth Rate (2014-2019) 4.4 Asia-Pacific Biologics and Biosimilars Sales and Growth Rate (2014-2019) 4.5 South America Biologics and Biosimilars Sales and Growth Rate (2014-2019) 4.6 Middle East and Africa Biologics and Biosimilars Sales and Growth Rate (2014-2019) 5 North America Biologics and Biosimilars by Country 5.1 North America Biologics and Biosimilars Sales, Revenue and Market Share by Country 5.1.1 North America Biologics and Biosimilars Sales and Market Share by Country (2014-2019) 5.1.2 North America Biologics and Biosimilars Revenue and Market Share by Country (2014-2019) 5.2 United States Biologics and Biosimilars Sales and Growth Rate (2014-2019) 5.3 Canada Biologics and Biosimilars Sales and Growth Rate (2014-2019) 5.4 Mexico Biologics and Biosimilars Sales and Growth Rate (2014-2019) 6 Europe Biologics and Biosimilars by Country 6.1 Europe Biologics and Biosimilars Sales, Revenue and Market Share by Country 6.1.1 Europe Biologics and Biosimilars Sales and Market Share by Country (2014-2019) 6.1.2 Europe Biologics and Biosimilars Revenue and Market Share by Country (2014-2019) 6.2 Germany Biologics and Biosimilars Sales and Growth Rate (2014-2019) 6.3 UK Biologics and Biosimilars Sales and Growth Rate (2014-2019) 6.4 France Biologics and Biosimilars Sales and Growth Rate (2014-2019) 6.5 Russia Biologics and Biosimilars Sales and Growth Rate (2014-2019) 6.6 Italy Biologics and Biosimilars Sales and Growth Rate (2014-2019) 7 Asia-Pacific Biologics and Biosimilars by Country 7.1 Asia-Pacific Biologics and Biosimilars Sales, Revenue and Market Share by Country 7.1.1 Asia-Pacific Biologics and Biosimilars Sales and Market Share by Country (2014-2019) 7.1.2 Asia-Pacific Biologics and Biosimilars Revenue and Market Share by Country (2014-2019) 7.2 China Biologics and Biosimilars Sales and Growth Rate (2014-2019) 7.3 Japan Biologics and Biosimilars Sales and Growth Rate (2014-2019) 7.4 Korea Biologics and Biosimilars Sales and Growth Rate (2014-2019) 7.5 India Biologics and Biosimilars Sales and Growth Rate (2014-2019) 7.6 Southeast Asia Biologics and Biosimilars Sales and Growth Rate (2014-2019) 8 South America Biologics and Biosimilars by Country 8.1 South America Biologics and Biosimilars Sales, Revenue and Market Share by Country 8.1.1 South America Biologics and Biosimilars Sales and Market Share by Country (2014-2019) 8.1.2 South America Biologics and Biosimilars Revenue and Market Share by Country (2014-2019) 8.2 Brazil Biologics and Biosimilars Sales and Growth Rate (2014-2019) 8.3 Argentina Biologics and Biosimilars Sales and Growth Rate (2014-2019) 8.4 Colombia Biologics and Biosimilars Sales and Growth Rate (2014-2019) 9 Middle East and Africa Biologics and Biosimilars by Countries 9.1 Middle East and Africa Biologics and Biosimilars Sales, Revenue and Market Share by Country 9.1.1 Middle East and Africa Biologics and Biosimilars Sales and Market Share by Country (2014-2019) 9.1.2 Middle East and Africa Biologics and Biosimilars Revenue and Market Share by Country (2014-2019) 9.2 Saudi Arabia Biologics and Biosimilars Sales and Growth Rate (2014-2019) 9.3 Turkey Biologics and Biosimilars Sales and Growth Rate (2014-2019) 9.4 Egypt Biologics and Biosimilars Sales and Growth Rate (2014-2019) 9.5 Nigeria Biologics and Biosimilars Sales and Growth Rate (2014-2019) 9.6 South Africa Biologics and Biosimilars Sales and Growth Rate (2014-2019) 10 Global Biologics and Biosimilars Market Segment by Type 10.1 Global Biologics and Biosimilars Sales, Revenue and Market Share by Type (2014-2019) 10.1.1 Global Biologics and Biosimilars Sales and Market Share by Type (2014-2019) 10.1.2 Global Biologics and Biosimilars Revenue and Market Share by Type (2014-2019) 10.2 Monoclonal Antibodies Sales Growth and Price 10.2.1 Global Monoclonal Antibodies Sales Growth (2014-2019) 10.2.2 Global Monoclonal Antibodies Price (2014-2019) 10.3 Interferon Sales Growth and Price 10.3.1 Global Interferon Sales Growth (2014-2019) 10.3.2 Global Interferon Price (2014-2019) 10.4 Erythropoietin Sales Growth and Price 10.4.1 Global Erythropoietin Sales Growth (2014-2019) 10.4.2 Global Erythropoietin Price (2014-2019) 10.5 Insulin Sales Growth and Price 10.5.1 Global Insulin Sales Growth (2014-2019) 10.5.2 Global Insulin Price (2014-2019) 10.6 Vaccines Sales Growth and Price 10.6.1 Global Vaccines Sales Growth (2014-2019) 10.6.2 Global Vaccines Price (2014-2019) 10.7 Other Sales Growth and Price 10.7.1 Global Other Sales Growth (2014-2019) 10.7.2 Global Other Price (2014-2019) 11 Global Biologics and Biosimilars Market Segment by Application 11.1 Global Biologics and Biosimilars Sales Market Share by Application (2014-2019) 11.2 Tumor Sales Growth (2014-2019) 11.3 Diabetes Sales Growth (2014-2019) 11.4 Cardiovascular Sales Growth (2014-2019) 11.5 Hemophilia Sales Growth (2014-2019) 11.6 Other Sales Growth (2014-2019) 12 Biologics and Biosimilars Market Forecast (2019-2024) 12.1 Global Biologics and Biosimilars Sales, Revenue and Growth Rate (2019-2024) 12.2 Biologics and Biosimilars Market Forecast by Regions (2019-2024) 12.2.1 North America Biologics and Biosimilars Market Forecast (2019-2024) 12.2.2 Europe Biologics and Biosimilars Market Forecast (2019-2024) 12.2.3 Asia-Pacific Biologics and Biosimilars Market Forecast (2019-2024) 12.2.4 South America Biologics and Biosimilars Market Forecast (2019-2024) 12.2.5 Middle East and Africa Biologics and Biosimilars Market Forecast (2019-2024) 12.3 Biologics and Biosimilars Market Forecast by Type (2019-2024) 12.3.1 Global Biologics and Biosimilars Sales Forecast by Type (2019-2024) 12.3.2 Global Biologics and Biosimilars Market Share Forecast by Type (2019-2024) 12.4 Biologics and Biosimilars Market Forecast by Application (2019-2024) 12.4.1 Global Biologics and Biosimilars Sales Forecast by Application (2019-2024) 12.4.2 Global Biologics and Biosimilars Market Share Forecast by Application (2019-2024) 13 Sales Channel, Distributors, Traders and Dealers 13.1 Sales Channel 13.1.1 Direct Marketing 13.1.2 Indirect Marketing 13.1.3 Marketing Channel Future Trend 13.2 Distributors, Traders and Dealers 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology 15.2 Data Source
1133

2663

OUR CLIENT